Viewing Study NCT04472767


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2025-12-27 @ 5:11 AM
Study NCT ID: NCT04472767
Status: RECRUITING
Last Update Posted: 2025-04-30
First Post: 2020-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
Sponsor: University of California, Irvine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module